Published in Eur Child Adolesc Psychiatry on November 29, 2013
Impact of NEGR1 genetic variability on psychological traits of patients with eating disorders. Pharmacogenomics J (2014) 0.77
Identification of determinants of referral and follow-up body mass index of adolescent patients with anorexia nervosa: evidence for the role of premorbid body weight. Eur Child Adolesc Psychiatry (2015) 0.76
TOX and ADIPOQ Gene Polymorphisms Are Associated with Antipsychotic-Induced Weight Gain in Han Chinese. Sci Rep (2017) 0.75
Association between obesity and the brain-derived neurotrophic factor gene polymorphism Val66Met in individuals with bipolar disorder in Mexican population. Neuropsychiatr Dis Treat (2016) 0.75
Evidence for three genetic loci involved in both anorexia nervosa risk and variation of body mass index. Mol Psychiatry (2016) 0.75
Influence of TFAP2B and KCTD15 genetic variability on personality dimensions in anorexia and bulimia nervosa. Brain Behav (2017) 0.75
PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet (2007) 209.92
Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat Genet (2010) 23.08
A neurotrophic model for stress-related mood disorders. Biol Psychiatry (2006) 8.97
SNPStats: a web tool for the analysis of association studies. Bioinformatics (2006) 5.84
SNP genotyping using the Sequenom MassARRAY iPLEX platform. Curr Protoc Hum Genet (2009) 5.01
Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry (2008) 4.06
BDNF regulates eating behavior and locomotor activity in mice. EMBO J (2000) 3.52
Brain-derived neurotrophic factor Val66Met and psychiatric disorders: meta-analysis of case-control studies confirm association to substance-related disorders, eating disorders, and schizophrenia. Biol Psychiatry (2007) 2.55
A BDNF coding variant is associated with the NEO personality inventory domain neuroticism, a risk factor for depression. Neuropsychopharmacology (2002) 2.07
Risk factors for bulimia nervosa. A community-based case-control study. Arch Gen Psychiatry (1997) 2.05
Association of a functional BDNF polymorphism and anxiety-related personality traits. Psychopharmacology (Berl) (2005) 1.77
Symptom fluctuation in eating disorders: correlates of diagnostic crossover. Am J Psychiatry (2005) 1.69
BDNF serum concentrations in healthy volunteers are associated with depression-related personality traits. Neuropsychopharmacology (2004) 1.44
Mutation screen of the brain derived neurotrophic factor gene (BDNF): identification of several genetic variants and association studies in patients with obesity, eating disorders, and attention-deficit/hyperactivity disorder. Am J Med Genet B Neuropsychiatr Genet (2005) 1.22
Association of BDNF with anorexia, bulimia and age of onset of weight loss in six European populations. Hum Mol Genet (2004) 1.20
Association of BDNF with restricting anorexia nervosa and minimum body mass index: a family-based association study of eight European populations. Eur J Hum Genet (2005) 1.13
The genetics of anorexia nervosa collaborative study: methods and sample description. Int J Eat Disord (2008) 1.12
BDNF Val66Met is associated with introversion and interacts with 5-HTTLPR to influence neuroticism. Neuropsychopharmacology (2009) 1.11
Association study of 182 candidate genes in anorexia nervosa. Am J Med Genet B Neuropsychiatr Genet (2010) 1.11
Temperament and character in women with anorexia nervosa. J Nerv Ment Dis (2000) 1.11
Met66 in the brain-derived neurotrophic factor (BDNF) precursor is associated with anorexia nervosa restrictive type. Mol Psychiatry (2003) 1.09
Molecular mechanisms underlying anorexia nervosa: focus on human gene association studies and systems controlling food intake. Brain Res Rev (2009) 1.07
Understanding persistence in bulimia nervosa: a 5-year naturalistic study. J Consult Clin Psychol (2003) 1.04
Altered brain-derived neurotrophic factor blood levels and gene variability are associated with anorexia and bulimia. Genes Brain Behav (2007) 1.01
Brain-derived neurotrophic factor, food intake regulation, and obesity. Arch Med Res (2011) 0.98
A DRD4/BDNF gene-gene interaction associated with maximum BMI in women with bulimia nervosa. Int J Eat Disord (2008) 0.97
Effects of BDNF polymorphisms on brain function and behavior in health and disease. Brain Res Bull (2011) 0.94
Influence of BDNF variants on diagnosis and response to treatment in patients with major depression, bipolar disorder and schizophrenia. Neuropsychobiology (2011) 0.93
Weighing in the role of BDNF in the central control of eating behavior. Mol Neurobiol (2011) 0.93
Family trios analysis of common polymorphisms in the obestatin/ghrelin, BDNF and AGRP genes in patients with Anorexia nervosa: association with subtype, body-mass index, severity and age of onset. Psychoneuroendocrinology (2007) 0.90
Genetic susceptibility to eating disorders: associated polymorphisms and pharmacogenetic suggestions. Pharmacogenomics (2008) 0.86
The genetics of anorexia nervosa. Clin Pharmacol Ther (2011) 0.85
Non-eating disorders psychopathology in children and adolescents with eating disorders: implications for malnutrition and symptom severity. J Psychosom Res (2006) 0.85
Low serum BDNF and food intake regulation: a possible new explanation of the pathophysiology of eating disorders. Prog Neuropsychopharmacol Biol Psychiatry (2008) 0.84
Genetics of serum BDNF: meta-analysis of the Val66Met and genome-wide association study. World J Biol Psychiatry (2011) 0.83
Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients. Neuropsychobiology (2008) 0.82
BDNF variability in opioid addicts and response to methadone treatment: preliminary findings. Genes Brain Behav (2008) 0.82
Brain derived neurotrophic factor gene Val66Met and -270C/T polymorphisms and personality traits predisposing to anorexia nervosa. Neuro Endocrinol Lett (2007) 0.82
The 196G/A (val66met) polymorphism of the BDNF gene is significantly associated with binge eating behavior in women with bulimia nervosa or binge eating disorder. Neurosci Lett (2006) 0.82
Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features. J Clin Psychopharmacol (2013) 0.82
BDNF Met66 allele is associated with anorexia nervosa in the Polish population. Psychiatr Genet (2007) 0.81
Personality development characteristics of women with anorexia nervosa, their healthy siblings and healthy controls: What prevents and what relates to psychopathology? Psychiatry Res (2010) 0.80
Polymorphisms in the brain-derived neurotrophic factor gene are not associated with either anorexia nervosa or schizophrenia in Dutch patients. Psychiatr Genet (2005) 0.80
Correlation of BDNF blood levels with interoceptive awareness and maturity fears in anorexia and bulimia nervosa patients. J Neural Transm (Vienna) (2010) 0.80
The Val66Met polymorphism of the BDNF gene in anorexia nervosa: new data and a meta-analysis. World J Biol Psychiatry (2011) 0.80
Polymorphisms in serotonergic genes and psychopathological traits in eating disorders. J Clin Psychopharmacol (2012) 0.79
Short-term follow-up of adults with long standing anorexia nervosa or non-specified eating disorder after inpatient treatment. Eat Weight Disord (2004) 0.76
New insights into the mechanisms underlying the effects of BDNF on eating behavior. Neuropsychopharmacology (2011) 0.76
Genetic association between BDNF gene polymorphisms and phobic disorders: a case-control study among mainland Han Chinese. J Affect Disord (2011) 0.76
No association of brain-derived neurotrophic factor Val66Met polymorphism with anorexia nervosa in Japanese. Am J Med Genet B Neuropsychiatr Genet (2011) 0.76
Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women. Pharmacogenetics (2003) 2.03
Essential cell division protein FtsZ assembles into one monomer-thick ribbons under conditions resembling the crowded intracellular environment. J Biol Chem (2003) 1.83
Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): implications for altered drug disposition and central nervous system drug entry. J Biol Chem (2005) 1.56
Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: a high proportion of mutations unique to Spain and evidence of founder effects. Hum Mutat (2003) 1.54
Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer. Int J Cancer (2002) 1.44
Diagnostic utility of HFE variants in Spanish patients: association with HLA alleles and role in susceptibility to acute lymphoblastic leukemia. Gene (2012) 1.43
GST polymorphisms interact with dietary factors to modulate lung cancer risk: study in a high-incidence area. Nutr Cancer (2010) 1.42
Cooperative behavior of Escherichia coli cell-division protein FtsZ assembly involves the preferential cyclization of long single-stranded fibrils. Proc Natl Acad Sci U S A (2005) 1.36
The breast cancer low-penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population. Int J Cancer (2004) 1.24
Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine. J Clin Psychopharmacol (2003) 1.21
Sedimentation equilibrium in a solution containing an arbitrary number of solute species at arbitrary concentrations: theory and application to concentrated solutions of ribonuclease. Biophys Chem (2004) 1.15
Genetic polymorphism of CYP1A2 in Ethiopians affecting induction and expression: characterization of novel haplotypes with single-nucleotide polymorphisms in intron 1. Mol Pharmacol (2003) 1.05
Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutations. Eur J Hum Genet (2003) 1.02
Isolation, characterization and lipid-binding properties of the recalcitrant FtsA division protein from Escherichia coli. PLoS One (2012) 0.97
Bacterial division proteins FtsZ and ZipA induce vesicle shrinkage and cell membrane invagination. J Biol Chem (2013) 0.96
A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression. Mol Endocrinol (2007) 0.94
Development of a homogeneous fluorescence anisotropy assay to monitor and measure FtsZ assembly in solution. Anal Biochem (2011) 0.94
Optimization of the palindromic order of the TtgR operator enhances binding cooperativity. J Mol Biol (2007) 0.92
The transcriptional repressor TtgV recognizes a complex operator as a tetramer and induces convex DNA bending. J Mol Biol (2007) 0.92
CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: a case control study. BMC Cancer (2010) 0.92
Current review of genetics of human obesity: from molecular mechanisms to an evolutionary perspective. Mol Genet Genomics (2015) 0.90
FtsZ polymers bound to lipid bilayers through ZipA form dynamic two dimensional networks. Biochim Biophys Acta (2011) 0.90
Multiple, non-conserved, internal viral ligands naturally presented by HLA-B27 in human respiratory syncytial virus-infected cells. Mol Cell Proteomics (2010) 0.88
Low daily 10-mg and 20-mg doses of fluvoxamine inhibit the metabolism of both caffeine (cytochrome P4501A2) and omeprazole (cytochrome P4502C19). Clin Pharmacol Ther (2002) 0.88
Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds. Clin Pharmacokinet (2004) 0.87
Adenosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer. Cancer (2006) 0.86
Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy. Eur J Clin Pharmacol (2010) 0.86
In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population. Eur J Clin Pharmacol (2010) 0.86
Thrombocytopenia and fatality associated with olanzapine. Eur J Clin Pharmacol (2004) 0.85
Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis. Am J Hematol (2011) 0.85
Xanthine oxidase activity is influenced by environmental factors in Ethiopians. Eur J Clin Pharmacol (2003) 0.85
H-2Ld class I molecule protects an HIV N-extended epitope from in vitro trimming by endoplasmic reticulum aminopeptidase associated with antigen processing. J Immunol (2010) 0.84
FTO risk haplotype among early onset and severe obesity cases in a population of western Spain. Obesity (Silver Spring) (2011) 0.84
Genetic characterization and structural analysis of VHL Spanish families to define genotype-phenotype correlations. Hum Mutat (2004) 0.84
Comparison of N-acetyltransferase-2 enzyme genotype-phenotype and xanthine oxidase enzyme activity between Swedes and Koreans. J Clin Pharmacol (2011) 0.84
Multiple viral ligands naturally presented by different class I molecules in transporter antigen processing-deficient vaccinia virus-infected cells. J Virol (2011) 0.83
ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients. Eur J Clin Pharmacol (2012) 0.83
Antigen processing of a short viral antigen by proteasomes. J Biol Chem (2006) 0.83
Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and Other Caucasian populations. Ther Drug Monit (2005) 0.83
Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain. Front Genet (2012) 0.82
Towards a bottom-up reconstitution of bacterial cell division. Trends Cell Biol (2012) 0.82
Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features. J Clin Psychopharmacol (2013) 0.82
Natural HLA-B*2705 protein ligands with glutamine as anchor motif: implications for HLA-B27 association with spondyloarthropathy. J Biol Chem (2013) 0.82
The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 polymorphisms and gender on the urinary excretion of the metabolites of the H-receptor antihistamine ebastine: a pilot study. Br J Clin Pharmacol (2006) 0.81
High CYP2A6 enzyme activity as measured by a caffeine test and unique distribution of CYP2A6 variant alleles in Ethiopian population. OMICS (2013) 0.81
Unusual viral ligand with alternative interactions is presented by HLA-Cw4 in human respiratory syncytial virus-infected cells. Immunol Cell Biol (2010) 0.80
Association equilibrium of the HIV-1 capsid protein in a crowded medium reveals that hexamerization during capsid assembly requires a functional C-domain dimerization interface. Biophys J (2013) 0.80
Concerted antigen processing of a short viral antigen by human caspase-5 and -10. J Biol Chem (2011) 0.80
Polymorphisms in TRAIL receptor genes and risk of breast cancer in Spanish women. Cancer Biomark (2007) 0.80
Concerted in vitro trimming of viral HLA-B27-restricted ligands by human ERAP1 and ERAP2 aminopeptidases. PLoS One (2013) 0.80
Diversity of natural self-derived ligands presented by different HLA class I molecules in transporter antigen processing-deficient cells. PLoS One (2013) 0.80
Haplotypes in the 5'-untranslated region of the CYP1A2 gene are inversely associated with lung cancer risk but do not correlate with caffeine metabolism. Environ Mol Mutagen (2012) 0.80
Polymorphisms in serotonergic genes and psychopathological traits in eating disorders. J Clin Psychopharmacol (2012) 0.79
Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma. Crit Rev Oncol Hematol (2012) 0.79
TAP-independent human histocompatibility complex-Cw1 antigen processing of an HIV envelope protein conserved peptide. AIDS (2011) 0.79
Analytical ultracentrifugation studies of phage phi29 protein p6 binding to DNA. J Mol Biol (2008) 0.78
Comparisons of CYP2A6 genotype and enzyme activity between Swedes and Koreans. Drug Metab Pharmacokinet (2012) 0.78
Diagnostic and therapeutic challenges of primary autoimmune haemolytic anaemia in children. Arch Dis Child (2014) 0.78
Distinct mechanism of formation of the 48, XXYY karyotype. Mol Cytogenet (2013) 0.77
N-Acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in Serbs: unprecedented high prevalence of rapid acetylators in a White population. J Clin Pharmacol (2010) 0.77
Evaluation of a drug-drug interaction alert structure through the retrospective analysis of statins-macrolides co-prescriptions. Basic Clin Pharmacol Toxicol (2005) 0.76
Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care setting. Ann Pharmacother (2009) 0.75
A viral, transporter associated with antigen processing (TAP)-independent, high affinity ligand with alternative interactions endogenously presented by the nonclassical human leukocyte antigen E class I molecule. J Biol Chem (2012) 0.75
Ethylenediaminetetraacetic acid-dependent pseudomacrocytosis. J Clin Pathol (2013) 0.75
Strategy for fluorescent labeling of human acidic fibroblast growth factor without impairment of mitogenic activity: a bona fide tracer. Anal Biochem (2010) 0.75
Polymorphism of FtsZ filaments on lipid surfaces: role of monomer orientation. Langmuir (2013) 0.75
Using a computerized drug prescription screening system to trace drug interactions in an outpatient setting. Ann Pharmacother (2004) 0.75
Retinal toxic reactions following photopheresis. Arch Dermatol (2007) 0.75
Novel variants in the MC4R and LEPR genes among severely obese children from the Iberian population. Ann Hum Genet (2014) 0.75
Thalassemia diagnosis in a blood donor from a unique trimorphic red blood cell population observed in the recipient. Clin Chem Lab Med (2014) 0.75
Dihydrofolate Reductase Genetic Polymorphisms Affect Methotrexate Dose Requirements in Pediatric Patients With Acute Lymphoblastic Leukemia on Maintenance Therapy. J Pediatr Hematol Oncol (2017) 0.75
Early detection of drug interactions utilizing a computerized drug prescription handling system-focus on cerivastatin-gemfibrozil. Eur J Clin Pharmacol (2004) 0.75
Previously Undescribed Family Mutation in the JAG1 Gene as a Cause for Alagille Syndrome. J Pediatr Gastroenterol Nutr (2017) 0.75
Structural and functional analysis of phi29 p16.7C dimerization mutants: identification of a novel aromatic cage dimerization motif. J Biol Chem (2007) 0.75
Melanocortin-4 receptor gene variants are not associated with binge-eating behavior in nonobese patients with eating disorders. Psychiatr Genet (2015) 0.75
Applicability of an assay for routine monitoring of highly variable concentrations of olanzapine based on HPLC with mass spectrometric detection. Clin Chem (2003) 0.75
Tyrosinase inhibitory activity of cucumber compounds: enzymes responsible for browning in cucumber. J Agric Food Chem (2003) 0.75